Beta Bionics, Inc. (BBNX)
NASDAQ: BBNX · Real-Time Price · USD
29.38
-0.62 (-2.07%)
Dec 5, 2025, 4:00 PM EST - Market closed

Beta Bionics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22
1,293---
Enterprise Value
1,072---
Debt / Equity Ratio
0.030.100.070.32
Asset Turnover
0.420.500.17-
Inventory Turnover
2.554.01--
Quick Ratio
9.575.479.543.12
Current Ratio
10.646.299.773.21
Return on Equity (ROE)
-47.52%-81.35%-123.17%-
Return on Assets (ROA)
-20.08%-21.78%-30.79%-
Return on Capital (ROIC)
-25.03%-38.72%-56.04%-
Return on Capital Employed (ROCE)
-22.50%-35.20%-36.10%-242.90%
Buyback Yield / Dilution
-401.81%-20.01%-6.13%-
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q